We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Advanced Medical Solutions Group Plc | LSE:AMS | London | Ordinary Share | GB0004536594 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.40 | 1.24% | 195.40 | 194.80 | 195.60 | 195.60 | 192.00 | 192.40 | 342,131 | 16:35:23 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Plastics,resins,elastomers | 126.21M | 15.89M | 0.0732 | 26.67 | 424M |
From May 2019 to May 2024
TIDMAMS
RNS Number : 0169R
Advanced Medical Solutions Grp PLC
24 June 2015
24 June 2015
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Capital Markets Day
Winsford, UK, 24 June 2015 - Advanced Medical Solutions Group plc (AIM: AMS.L), the surgical and advanced woundcare specialist company, will today host a Capital Markets Day for financial analysts and institutional investors from 12:30 - 16:00 GMT, in London.
The event, which will provide an opportunity for participants to meet some of the Group's senior management team, will begin with a short corporate update on strategy from Chris Meredith, Chief Executive Officer, followed by a focus on LiquiBand(R) in the US market, a surgeon discussion led by Assistant Professor Bernhard Dauser from the Department of Surgery at St John of God Hospital, Vienna, on the benefits of LiquiBand(R) Fix 8(R) , and a session on innovation and market opportunities across the complete AMS product platform.
No new material information will be disclosed during the event.
For more information, please contact ams@consilium-comms.com or call +44 (0) 20 3709 5700.
- Ends -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director +44 (0) 1606 545508 Consilium Strategic Communications +44 (0) 20 3709 5700 Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan AMS@consilium-comms.com
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in 65 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 470 employees. For more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKKDADSSEFF
1 Year Advanced Medical Solutions Chart |
1 Month Advanced Medical Solutions Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
